Sverchkova, Angelina
Burkholz, Scott
Rubsamen, Reid
Stratford, Richard
Clancy, Trevor
Funding for this research was provided by:
Norges Forskningsråd
Article History
Received: 5 July 2023
Accepted: 12 January 2024
First Online: 27 January 2024
Declarations
:
: This study was approved by the Reno Institutional Review Board of the University of Nevada. All the experiments were performed in accordance with relevant guidelines and regulations. The informed consent was obtained from all patients involved in the study.
: Not applicable.
: T.C., R.S., and A.S., declare they have an affiliation to the NEC OncoImmunity company. S.B. and R.R. declare they have an affiliation to the Flow Pharma Inc. company.